BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 9242537)

  • 1. Human neutrophil elastase activates human factor V but inactivates thrombin-activated human factor V.
    Samis JA; Garrett M; Manuel RP; Nesheim ME; Giles AR
    Blood; 1997 Aug; 90(3):1065-74. PubMed ID: 9242537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteolysis of factor V by cathepsin G and elastase indicates that cleavage at Arg1545 optimizes cofactor function by facilitating factor Xa binding.
    Camire RM; Kalafatis M; Tracy PB
    Biochemistry; 1998 Aug; 37(34):11896-906. PubMed ID: 9718313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mechanism of inactivation of human factor V and human factor Va by activated protein C.
    Kalafatis M; Rand MD; Mann KG
    J Biol Chem; 1994 Dec; 269(50):31869-80. PubMed ID: 7989361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein C activation and factor Va inactivation on human umbilical vein endothelial cells.
    Hockin MF; Kalafatis M; Shatos M; Mann KG
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2765-75. PubMed ID: 9409254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cleavage requirements for activation of factor V by factor Xa.
    Thorelli E; Kaufman RJ; Dahlbäck B
    Eur J Biochem; 1997 Jul; 247(1):12-20. PubMed ID: 9249003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteolytic events that regulate factor V activity in whole plasma from normal and activated protein C (APC)-resistant individuals during clotting: an insight into the APC-resistance assay.
    Kalafatis M; Haley PE; Lu D; Bertina RM; Long GL; Mann KG
    Blood; 1996 Jun; 87(11):4695-707. PubMed ID: 8639839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mechanism of inactivation of human platelet factor Va from normal and activated protein C-resistant individuals.
    Camire RM; Kalafatis M; Cushman M; Tracy RP; Mann KG; Tracy PB
    J Biol Chem; 1995 Sep; 270(35):20794-800. PubMed ID: 7657663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of Arg306-->Ala and Arg506-->Gln substitutions in the inactivation of recombinant human factor Va by activated protein C and protein S.
    Egan JO; Kalafatis M; Mann KG
    Protein Sci; 1997 Sep; 6(9):2016-27. PubMed ID: 9300501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutrophil elastase cleavage of human factor IX generates an activated factor IX-like product devoid of coagulant function.
    Samis JA; Kam E; Nesheim ME; Giles AR
    Blood; 1998 Aug; 92(4):1287-96. PubMed ID: 9694717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the molecular defect in factor VR506Q.
    Kalafatis M; Bertina RM; Rand MD; Mann KG
    J Biol Chem; 1995 Feb; 270(8):4053-7. PubMed ID: 7876154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The regulation of human factor V by a neutrophil protease.
    Oates AM; Salem HH
    Blood; 1987 Sep; 70(3):846-51. PubMed ID: 3304463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thromsbospondin-1 binds to the heavy chain of elastase activated coagulation factor V (FVaHNE) and enhances thrombin generation on the surface of a promyelocytic cell line.
    Isordia-Salas I; Manns JM; Sainz I; Parekh H; DeLa Cadena RA
    Thromb Res; 2005; 116(6):533-43. PubMed ID: 16181989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of human factor V by factor Xa and thrombin.
    Monkovic DD; Tracy PB
    Biochemistry; 1990 Feb; 29(5):1118-28. PubMed ID: 2322551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of bovine factor V by an activator purified from the venom of Naja naja oxiana.
    Gerads I; Tans G; Yukelson LYa ; Zwaal RF; Rosing J
    Toxicon; 1992 Sep; 30(9):1065-79. PubMed ID: 1440644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteolysis of factor Va by factor Xa and activated protein C.
    Odegaard B; Mann K
    J Biol Chem; 1987 Aug; 262(23):11233-8. PubMed ID: 3611108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptide bond cleavages and loss of functional activity during inactivation of factor Va and factor VaR506Q by activated protein C.
    Nicolaes GA; Tans G; Thomassen MC; Hemker HC; Pabinger I; Varadi K; Schwarz HP; Rosing J
    J Biol Chem; 1995 Sep; 270(36):21158-66. PubMed ID: 7673148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bothrojaracin, a proexosite I ligand, inhibits factor Va-accelerated prothrombin activation.
    Monteiro RQ; Zingali RB
    Thromb Haemost; 2002 Feb; 87(2):288-93. PubMed ID: 11858489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The factor Xa-catalyzed activation of factor V.
    Foster WB; Nesheim ME; Mann KG
    J Biol Chem; 1983 Nov; 258(22):13970-7. PubMed ID: 6643460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet-derived factor Va/Va Leiden cofactor activities are sustained on the surface of activated platelets despite the presence of activated protein C.
    Camire RM; Kalafatis M; Simioni P; Girolami A; Tracy PB
    Blood; 1998 Apr; 91(8):2818-29. PubMed ID: 9531592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbohydrate moieties on the procofactor factor V, but not the derived cofactor factor Va, regulate its inactivation by activated protein C.
    Silveira JR; Kalafatis M; Tracy PB
    Biochemistry; 2002 Feb; 41(5):1672-80. PubMed ID: 11814362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.